Despite the earlier belief that neutralizing TRAIL protein by antibodies that block the initiation of TRAIL signals is a risky approach because TRAIL plays a crucial role in immune surveillance,96 an experiment on the triple transgenic mouse model of Alzheimer's disease applying this method of neutralization of TRAIL achieved notable results.98 The gene discussed is TNFSF10; the disease is early-onset autosomal dominant Alzheimer disease.